Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Cephalon Earnings Beat Consensus, But Opinion Split On Future

Feb 12 2008

• By Randall Osborne

Related Content

Cephalon Files Treanda For NHL Indication

Jan 02 2008

FDA Approves Cephalon’s Nuvigil With Bolded Warning For Rash

Jun 18 2007

Cephalon Settles Federal Investigation Of Marketing Practices For $425 Million

Nov 09 2007

Cephalon Provigil Generics Settlements Under FTC Investigation

Aug 30 2006

Vivitrol Approved Labeling Leaves Room For Broad Marketing Plan

Apr 13 2006

Cephalon Adds Amrix To Pain Portfolio From ECR Pharmaceuticals Deal

Aug 23 2007

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window